Gladstone NOW: The Campaign Join Us on the Journey ✕
946 - 960 of 1505 Results Clear All
East Bay Business News—A Roche team in Pleasanton that monitors viral outbreaks started a process in late December 2019 that led this week to the first commercially approved test for COVID-19.
Gladstone Experts COVID-19
Questions answered from Gladstone experts about the COVID-19 pandemic.
Communications Gladstone Experts News Release COVID-19 Infectious Disease Greene Lab Ott Lab
The Mercury News—Senior Investigator Melanie Ott explains to Mercury News why coronavirus seems to affect some populations more than others.
Gladstone Experts COVID-19 Ott Lab
C&EN—See what a normal day is like for world-renowned scientist and inventor of CRISPR technology, Jennifer Doudna.
Gladstone Experts Doudna Lab
In 2016, Gladstone launched the Women’s Initiative with the mission to identify and address issues that affect women at Gladstone, and to foster a supportive network that connects them as they progress through their professional careers.
Womens Initiative Institutional News
During Gladstone's 40th Anniversary Science Symposium, the Gladstone Women’s Initiative hosted a special panel discussion on building a more inclusive environment and advocating for gender parity in the scientific field.
Womens Initiative Gladstone Experts Institutional News Pollard Lab
Pharmacy Times—Pharmacy Times reports on a recent study from Nevan Krogan’s lab that uses a large-scale genetic approach to uncover human genes controlling HIV infection.
Gladstone Experts Infectious Disease Krogan Lab
After months of research, collaboration, and development, Gladstone has launched a newly designed website.
Communications Institutional News
GEN—Genetic Engineering and Biotechnology News reports on a recent study from the lab of Lennart Mucke that shows how reducing levels of Tau, a protein associated with Alzheimer’s disease, could prevent some symptoms of autism.
Gladstone Experts Mucke Lab
Spectrum—Lowering the levels of a protein called tau, best known for its involvement in Alzheimer’s disease, eases autism-like traits in mice, according to a study from the lab of Lennart Mucke.
Gladstone Experts Mucke Lab
FierceBiotech—Fierce Biotech reports on a study that shows how reducing tau can prevent symptoms related to autism in mouse models.
Gladstone Experts
Technology Networks—A recent study from Senior Investigator Lennart Mucke and his team show how a protein related to Alzheimer’s disease could play a role in autism.
Gladstone Experts Mucke Lab
San Francisco Business Times—For companies working on a certain approach to Alzheimer’s disease, the findings could expand targets.
Gladstone Experts
New study shows reducing levels of the protein tau prevents core autism symptoms in animal models
News Release Research (Publication) Behavioral Core Histology and Light Microscopy Core Alzheimer’s Disease Neurological Disease Mucke Lab
In 2019, Gladstone launched the Responsible Conduct of Research seminar series as part of its comprehensive training program for postdocs and graduate students.
Postdoctoral and Graduate Student Education and Research Development Affairs Graduate Students and Postdocs Institutional News Conklin Lab Mahley Lab
